Remove 2026 Remove Drugs Remove Pharma Companies Remove Vaccine
article thumbnail

Changes to UK Statutory Scheme go ahead despite pharma criticism

Drug Discovery World

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8% While the published rates are down on the record 27.5%

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Automated systems have become a prominent feature throughout drug discovery, helping scientists save time and assisting in reproducible experiments for more verifiable results.

Drugs 130